Adrenal metastasis occurs when cancer cells spread to the adrenal glands from other parts of the body. Surgical management, particularly adrenalectomy (the surgical removal of the adrenal gland ...

Usually, it presents with no apparent signs or symptoms, unless the adrenal glands are producing excessive hormones (such as cortisol and aldosterone). This cancer can be aggressive, spread quickly, ...

Christophe M. Raynaud; Olaf Mercier; Philippe Dartevelle; Frédéric Commo; Ken André Olaussen; Vincent de Montpreville; Fabrice André; Laure Sabatier; Jean-Charles Soria ...

The obligatory adrenal insufficiency caused by surgery ... Mitotane should be started in patients with metastatic disease or a lack of surgical options, whether the tumor is functioning or not.

In the article by Hammerschmidt and Woitz, I missed a comment on the group of patients with stage IV non-small cell lung cancer as a result of isolated metastases in the brain or adrenal glands.

It is becoming increasingly clear that cancer cells play an active part in stimulating bone-marrow-derived cells (BMDCs) to create a microenvironment that is favourable for metastasis (the ...

and most severe side effects being adrenal insufficiency. The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic colorectal cancer.

A Phase II trial indicates that combining chemoradiotherapy with aggressive local consolidative therapy can improve survival ...

The FDA has accepted Merck's (NYSE:MRK) supplemental New Drug Application with priority review for its drug Welireg, also known as belzutifan, for the treatment of a rare type of adrenal gland tumors.

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...